Optimization of Treatment With Adalimumab (Humira)

This study has been completed.
Sponsor:
Collaborator:
Abbott
Information provided by (Responsible Party):
Janet Pope, Lawson Health Research Institute
ClinicalTrials.gov Identifier:
NCT01585064
First received: April 23, 2012
Last updated: April 24, 2012
Last verified: April 2012